Functional importance of the coiled-coil of the Ebola virus glycoprotein

Journal of Virology

Volumn 74, Issue 21, 2000, Pages 10194-10201

  Watanabe, S ^a   Takada, A ^a   Watanabe, T ^a   Ito, H ^a   Kida, H ^a   Kawaoka, Y ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; VIRUS GLYCOPROTEIN;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL SURFACE; EBOLA VIRUS; HOST CELL; MEMBRANE FUSION; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTEIN TRANSPORT; RECEPTOR BINDING; VESICULAR STOMATITIS VIRUS; VIRUS PARTICLE; VIRUS VIRULENCE;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL; CERCOPITHECUS AETHIOPS; EBOLA-LIKE VIRUSES; MEMBRANE FUSION; MOLECULAR SEQUENCE DATA; MUTATION; PEPTIDES; PROTEIN STRUCTURE, SECONDARY; STRUCTURE-ACTIVITY RELATIONSHIP; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; VERO CELLS; VESICULAR STOMATITIS-INDIANA VIRUS; VIRAL ENVELOPE PROTEINS; VIRAL FUSION PROTEINS;

EID: 0033771310     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.21.10194-10201.2000     Document Type: Article

References (55)

1. Structural basis for paramyxovirus-mediated membrane fusion
2. Oligomerization of the hydrophobic heptad repeat of gp41
3. Structure of influenza haemagglutinin at the pH of membrane fusion
4. Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41
5. Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein
6. A spring-loaded mechanism for the conformational change of influenza hemagglutinin
7. Core structure of gp41 from the HIV envelope glycoprotein
8. Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target
9. HIV entry and its inhibition
10. Mutational analysis of the leucine zipper-like motif of the human immunodeficiency virus type 1 envelope transmembrane glycoprotein
11. Functional role of the zipper motif region of human immunodeficiency virus type 1 transmembrane protein gp41
12. Mutations in the leucine zipper of the human immunodeficiency virus type 1 transmembrane glycoprotein affect fusion and infectivity
13. Paramyxovirus fusion protein: Characterization of the core trimer, a rod-shaped complex with helices in anti-parallel orientation
14. Retrovirus envelope domain at 1.7 Å resolution
15. Glycosylation and oligomerization of the spike protein of Marburg virus
16. Molecular biology and evolution of filoviruses
17. Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein
18. Similar structural models of the transmembrane proteins of Ebola and avian sarcoma viruses
19. Folding and function of a T4 lysozyme containing 10 consecutive alanines illustrate the redundancy of information in an amino acid sequence
20. Mutational analysis of the putative fusion domain of Ebola virus glycoprotein
21. Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses
22. HIV-1 inhibition by a peptide
23. A core trimer of the paramyxovirus fusion protein: Parallels to influenza virus hemagglutinin and HIV-1 gp41
24. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry
25. Crystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose-binding protein chimera reveals structural evolution of retroviral transmembrane proteins
26. Paramyxovirus fusion: A hypothesis for changes
27. Peptides from conserved regions paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion
28. Amino acid substitutions within the leucine zipper domain of the murine coronavirus spike protein cause defects in oligomerization and the ability to induce cell-to-cell
29. Side chain contributions to the stability of alpha-helical structure in peptides
30. Crystal structure of the simian immunodeficiency virus (SIV) gp41 core: Conserved helical interactions underlie the broad inhibitory activity of gp41 peptides
31. Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-resolution
32. Efficient selection for high-expression transfectants with a novel eukaryotic vector
33. The M2 ectodomain is important for its incorporation into influenza A virions
34. Filoviridae: Marburg and Ebola viruses
35. Human immunodeficiency virus type 1 envelope glycoprotein oligomerization requires the gp41 amphipathic α-helical/leucine zipper-like sequence
36. A synthetic peptide corresponding to a conserved heptad repeat domain is a potent inhibitor of Sendal virus-cell fusion: An emerging similarity with functional domains of other viruses
37. Mutational analysis of the leucine zipper motif in the Newcastle disease virus fusion protein
38. Phosphatidylinositol-dependent membrane fusion induced by a putative fusogenic sequence of Ebola virus
39. Sequence analysis of the Ebola virus genome: Organization, genetic elements, and comparison with the genome of Marburg virus
40. The virion glycoproteins Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing
41. Biochemical analysis of the secreted and virion glycoproteins of Ebola virus
42. DNA sequencing with chain-terminating inhibitors
43. HIV-1 entry inhibitors in the side pocket
44. A system for functional analysis of Ebola virus glycoprotein
45. Atomic structure of a thermostable subdomain of HIV-1 gp41
46. The envelope glycoprotein of Ebola virus contains an immunosuppressive-like domain similar to oncogenic retroviruses
47. Processing of the Ebola virus glycoprotein by the proprotein convertase furin
48. Atomic structure of the ectodomain from HIV-1 gp41
49. Crystal structure of the Ebola virus membrane fusion subunit. GP2, from the envelope glycoprotein ectodomain
50. Mutational analysis of residues in the coiled-coil domain of human immunodeficiency virus type 1 transmembrane protein gp41
51. A synthetic peptide inhibitor of human immunodeficiency virus replication: Correlation between solution structure and viral inhibition
52. Peptides corresponding to a predictive (α-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection
53. Characterization of Ebola virus entry by using pseudotyped viruses: Identification of receptor-deficient cell lines
54. Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins
55. Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection